[{"Assets_0_Q1_USD":264965000.0,"CommonStockSharesOutstanding_0_Q1_shares":133024000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-49955000.0,"NetIncomeLoss_1_Q1_USD":-38613000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":0.0,"StockholdersEquity_0_Q1_USD":-36311000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN INC","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]